This inventor holds 1 USPTO granted patent. Top assignee: Agy Therapeutics, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Huaiyu Mi - Innovator in Microglial Cell Purification
Introduction
Huaiyu Mi is a prominent inventor based in Fremont, CA (US). He has made significant contributions to the field of cellular biology, particularly in the purification of microglial cells. His innovative methods have the potential to advance research in neurological disorders.
Latest Patents
Huaiyu Mi holds a patent for a method titled "Purifying microglial cells by binding cell Fc receptor to immunoglobulin G Fc domain." This patent describes a technique for obtaining a cell population enriched in microglial cells. The method involves contacting a composition containing microglial cells with immunoglobulin immobilized on a matrix, such as a polystyrene matrix. This process allows the cells to bind to the immunoglobulin, followed by the removal of non-adherent cells, resulting in a population that contains at least 95% microglial cells. The immunoglobulin used may be F domain-containing immunoglobulin G, which binds to the F receptors of the microglial cells. This innovative approach can utilize purified F fragments from immunoglobulin G as an alternative to the full immunoglobulin G. The microglial cells can be sourced from brain tissue, whether from normal animals or those with neurological disorders. Huaiyu Mi has 1 patent to his name.
Career Highlights
Huaiyu Mi is currently associated with Agy Therapeutics, Inc., where he continues to develop and refine his innovative techniques. His work is instrumental in enhancing the understanding of microglial cells and their role in neurological health.
Collaborations
Huaiyu Mi collaborates with Saili Yi, contributing to advancements in their shared field of research.
Conclusion
Huaiyu Mi's contributions to the purification of microglial cells represent a significant advancement in cellular biology. His innovative methods hold promise for future research and therapeutic applications in the field of neurology.